Published in Nat Rev Drug Discov on February 01, 2008
A Within Subjects Comparison of Two Antegrade Flushing Regimens in Children | NCT02435069
Succession of microbial consortia in the developing infant gut microbiome. Proc Natl Acad Sci U S A (2010) 9.57
Bifidobacteria can protect from enteropathogenic infection through production of acetate. Nature (2011) 5.83
Functional characterization of the antibiotic resistance reservoir in the human microflora. Science (2009) 4.78
Pharmacometabonomic identification of a significant host-microbiome metabolic interaction affecting human drug metabolism. Proc Natl Acad Sci U S A (2009) 3.01
Gut microbiome-host interactions in health and disease. Genome Med (2011) 2.48
The human intestinal microbiome: a new frontier of human biology. DNA Res (2009) 2.30
Metabolic phenotyping in clinical and surgical environments. Nature (2012) 2.09
Targeting the human microbiome with antibiotics, probiotics, and prebiotics: gastroenterology enters the metagenomics era. Gastroenterology (2009) 1.96
Involvement of gut microbiota in the development of low-grade inflammation and type 2 diabetes associated with obesity. Gut Microbes (2012) 1.83
Human mucosal in vivo transcriptome responses to three lactobacilli indicate how probiotics may modulate human cellular pathways. Proc Natl Acad Sci U S A (2010) 1.56
Structural changes of gut microbiota during berberine-mediated prevention of obesity and insulin resistance in high-fat diet-fed rats. PLoS One (2012) 1.46
Structural resilience of the gut microbiota in adult mice under high-fat dietary perturbations. ISME J (2012) 1.46
Chapter 12: Human microbiome analysis. PLoS Comput Biol (2012) 1.44
Retracted Obesity as a consequence of gut bacteria and diet interactions. ISRN Obes (2014) 1.42
Patterns and scales in gastrointestinal microbial ecology. Gastroenterology (2009) 1.33
Phylotyping and functional analysis of two ancient human microbiomes. PLoS One (2008) 1.29
The gut microbiota: challenging immunology. Nat Rev Immunol (2011) 1.28
Metabonomic fingerprints of fasting plasma and spot urine reveal human pre-diabetic metabolic traits. Metabolomics (2010) 1.24
Evaluation and characterization of bacterial metabolic dynamics with a novel profiling technique, real-time metabolotyping. PLoS One (2009) 1.18
Therapeutic implications of manipulating and mining the microbiota. J Physiol (2009) 1.16
Modulation of the gut microbiota by nutrients with prebiotic properties: consequences for host health in the context of obesity and metabolic syndrome. Microb Cell Fact (2011) 1.16
'Gut health': a new objective in medicine? BMC Med (2011) 1.15
Gut microbiota and metabolic syndrome. World J Gastroenterol (2014) 1.14
Bioactivity enhancement of herbal supplements by intestinal microbiota focusing on ginsenosides. Am J Chin Med (2011) 1.13
Patient perceptions of fecal microbiota transplantation for ulcerative colitis. Inflamm Bowel Dis (2013) 1.13
metaXCMS: second-order analysis of untargeted metabolomics data. Anal Chem (2010) 1.10
Enteric pathogen exploitation of the microbiota-generated nutrient environment of the gut. Curr Opin Microbiol (2011) 1.09
Sucralose, a synthetic organochlorine sweetener: overview of biological issues. J Toxicol Environ Health B Crit Rev (2013) 1.06
Spatiotemporal modulation of biodiversity in a synthetic chemical-mediated ecosystem. Nat Chem Biol (2009) 1.05
Antipsychotics and the gut microbiome: olanzapine-induced metabolic dysfunction is attenuated by antibiotic administration in the rat. Transl Psychiatry (2013) 1.03
Engineering microbial systems to explore ecological and evolutionary dynamics. Curr Opin Biotechnol (2012) 0.99
Microbiome: That healthy gut feeling. Nature (2011) 0.97
Drugs, bugs, and personalized medicine: pharmacometabonomics enters the ring. Proc Natl Acad Sci U S A (2009) 0.96
Gut microbiome and metabolic diseases. Semin Immunopathol (2013) 0.96
Real-time analysis of gut flora in Entamoeba histolytica infected patients of Northern India. BMC Microbiol (2012) 0.94
Interactions of the intestinal epithelium with the pathogen and the indigenous microbiota: a three-way crosstalk. Interdiscip Perspect Infect Dis (2008) 0.92
Potential of probiotics, prebiotics and synbiotics for management of colorectal cancer. Gut Microbes (2013) 0.89
An environment-sensitive synthetic microbial ecosystem. PLoS One (2010) 0.89
Forensic DNA barcoding and bio-response studies of animal horn products used in traditional medicine. PLoS One (2013) 0.88
Helping patients make informed choices about probiotics: a need for research. Am J Gastroenterol (2009) 0.88
Metabolomic applications to decipher gut microbial metabolic influence in health and disease. Front Physiol (2012) 0.87
Immune disorders and its correlation with gut microbiome. Immune Netw (2012) 0.86
Phylogenetic and Metabolic Tracking of Gut Microbiota during Perinatal Development. PLoS One (2015) 0.84
Activation of Immune and Defense Responses in the Intestinal Mucosa by Outer Membrane Vesicles of Commensal and Probiotic Escherichia coli Strains. Front Microbiol (2016) 0.83
Microbiology: Genetic pot luck. Nature (2010) 0.83
Distinctly altered gut microbiota in the progression of liver disease. Oncotarget (2016) 0.82
Gut microbiota-involved mechanisms in enhancing systemic exposure of ginsenosides by coexisting polysaccharides in ginseng decoction. Sci Rep (2016) 0.81
Strain-level dissection of the contribution of the gut microbiome to human metabolic disease. Genome Med (2016) 0.81
Profiles of Microbial Fatty Acids in the Human Metabolome are Disease-Specific. Front Microbiol (2011) 0.81
Adapting functional genomic tools to metagenomic analyses: investigating the role of gut bacteria in relation to obesity. Brief Funct Genomics (2010) 0.81
The Gut Microbiome as Therapeutic Target in Central Nervous System Diseases: Implications for Stroke. Neurotherapeutics (2016) 0.81
Metagenomic surveys of gut microbiota. Genomics Proteomics Bioinformatics (2015) 0.81
Modulation of systemic immune responses through commensal gastrointestinal microbiota. PLoS One (2013) 0.80
An important role of interleukin-10 in counteracting excessive immune response in HT-29 cells exposed to Clostridium butyricum. BMC Microbiol (2012) 0.80
Molecular Insight into Gut Microbiota and Rheumatoid Arthritis. Int J Mol Sci (2016) 0.78
Combined probiotic bacteria promotes intestinal epithelial barrier function in interleukin-10-gene-deficient mice. World J Gastroenterol (2014) 0.78
Ambient Ultrafine Particle Ingestion Alters Gut Microbiota in Association with Increased Atherogenic Lipid Metabolites. Sci Rep (2017) 0.77
Isomer-specific consumption of galactooligosaccharides by bifidobacterial species. J Agric Food Chem (2013) 0.77
Intervention, integration and translation in obesity research: Genetic, developmental and metaorganismal approaches. Philos Ethics Humanit Med (2011) 0.77
Compression-based distance (CBD): a simple, rapid, and accurate method for microbiota composition comparison. BMC Bioinformatics (2013) 0.77
Differential responses of gut microbiota to the same prebiotic formula in oligotrophic and eutrophic batch fermentation systems. Sci Rep (2015) 0.75
Gut microbiota modulation of chemotherapy efficacy and toxicity. Nat Rev Gastroenterol Hepatol (2017) 0.75
Significant pharmacokinetic differences of berberine are attributable to variations in gut microbiota between Africans and Chinese. Sci Rep (2016) 0.75
Effects of turmeric curcuminoids and metformin against central sensitivity to pain in mice. J Tradit Complement Med (2016) 0.75
Dietary Keratan Sulfate from Shark Cartilage Modulates Gut Microbiota and Increases the Abundance of Lactobacillus spp. Mar Drugs (2016) 0.75
Compound danshen dripping pills modulate the perturbed energy metabolism in a rat model of acute myocardial ischemia. Sci Rep (2016) 0.75
Commensal gut bacteria modulate phosphorylation-dependent PPARγ transcriptional activity in human intestinal epithelial cells. Sci Rep (2017) 0.75
The intestinal microbiome and surgical disease. Curr Probl Surg (2016) 0.75
The Human Microbiome and the Immune System: An Ever Evolving Understanding. J Clin Cell Immunol (2014) 0.75
Antioxidant Drug Tempol Promotes Functional Metabolic Changes in the Gut Microbiota. J Proteome Res (2016) 0.75
Intestinal Dysbiosis and Rheumatoid Arthritis: A Link between Gut Microbiota and the Pathogenesis of Rheumatoid Arthritis. J Immunol Res (2017) 0.75
Receptor interacting protein kinase-3 determines cellular necrotic response to TNF-alpha. Cell (2009) 11.36
Symbiotic gut microbes modulate human metabolic phenotypes. Proc Natl Acad Sci U S A (2008) 6.42
Leptin regulates bone formation via the sympathetic nervous system. Cell (2002) 5.95
Metabolic profiling, metabolomic and metabonomic procedures for NMR spectroscopy of urine, plasma, serum and tissue extracts. Nat Protoc (2007) 5.92
Tissue-engineered lungs for in vivo implantation. Science (2010) 5.90
Human metabolic phenotype diversity and its association with diet and blood pressure. Nature (2008) 5.41
Systems biology: Metabonomics. Nature (2008) 5.32
Metabolic profiling reveals a contribution of gut microbiota to fatty liver phenotype in insulin-resistant mice. Proc Natl Acad Sci U S A (2006) 5.19
Rapid and noninvasive diagnosis of the presence and severity of coronary heart disease using 1H-NMR-based metabonomics. Nat Med (2002) 3.91
A top-down systems biology view of microbiome-mammalian metabolic interactions in a mouse model. Mol Syst Biol (2007) 3.68
Pharmaco-metabonomic phenotyping and personalized drug treatment. Nature (2006) 3.45
Metabolic surgery profoundly influences gut microbial-host metabolic cross-talk. Gut (2011) 3.42
Intraoperative tissue identification using rapid evaporative ionization mass spectrometry. Sci Transl Med (2013) 3.26
Pharmacometabonomic identification of a significant host-microbiome metabolic interaction affecting human drug metabolism. Proc Natl Acad Sci U S A (2009) 3.01
The ER UDPase ENTPD5 promotes protein N-glycosylation, the Warburg effect, and proliferation in the PTEN pathway. Cell (2010) 2.97
Metabolic profiling of CSF: evidence that early intervention may impact on disease progression and outcome in schizophrenia. PLoS Med (2006) 2.95
Structural segregation of gut microbiota between colorectal cancer patients and healthy volunteers. ISME J (2011) 2.92
Summary recommendations for standardization and reporting of metabolic analyses. Nat Biotechnol (2005) 2.90
A randomized trial of medical care management for community mental health settings: the Primary Care Access, Referral, and Evaluation (PCARE) study. Am J Psychiatry (2009) 2.90
Understanding excess mortality in persons with mental illness: 17-year follow up of a nationally representative US survey. Med Care (2011) 2.81
Metabolic phenotyping in health and disease. Cell (2008) 2.80
Interactions between gut microbiota, host genetics and diet relevant to development of metabolic syndromes in mice. ISME J (2009) 2.69
Systemic gut microbial modulation of bile acid metabolism in host tissue compartments. Proc Natl Acad Sci U S A (2010) 2.52
Gut microbiome-host interactions in health and disease. Genome Med (2011) 2.48
Probiotic modulation of symbiotic gut microbial-host metabolic interactions in a humanized microbiome mouse model. Mol Syst Biol (2008) 2.43
Global metabolic profiling procedures for urine using UPLC-MS. Nat Protoc (2010) 2.18
Systemic multicompartmental effects of the gut microbiome on mouse metabolic phenotypes. Mol Syst Biol (2008) 2.17
UPLC/MS(E); a new approach for generating molecular fragment information for biomarker structure elucidation. Rapid Commun Mass Spectrom (2006) 2.17
NMR-based metabonomic approaches for evaluating physiological influences on biofluid composition. NMR Biomed (2005) 2.15
Statins and cognitive decline in older adults with normal cognition or mild cognitive impairment. J Am Geriatr Soc (2013) 2.11
Metabonomic investigations in mice infected with Schistosoma mansoni: an approach for biomarker identification. Proc Natl Acad Sci U S A (2004) 2.11
Metabolic profiling of human colorectal cancer using high-resolution magic angle spinning nuclear magnetic resonance (HR-MAS NMR) spectroscopy and gas chromatography mass spectrometry (GC/MS). J Proteome Res (2009) 2.10
Nutrient starvation elicits an acute autophagic response mediated by Ulk1 dephosphorylation and its subsequent dissociation from AMPK. Proc Natl Acad Sci U S A (2011) 2.06
Colonization-induced host-gut microbial metabolic interaction. MBio (2011) 2.04
Optimized preprocessing of ultra-performance liquid chromatography/mass spectrometry urinary metabolic profiles for improved information recovery. Anal Chem (2011) 2.02
Global systems biology, personalized medicine and molecular epidemiology. Mol Syst Biol (2006) 1.99
How has healthcare research performance been assessed?: a systematic review. J R Soc Med (2011) 1.97
Susceptibility of human metabolic phenotypes to dietary modulation. J Proteome Res (2006) 1.96
High resolution "ultra performance" liquid chromatography coupled to oa-TOF mass spectrometry as a tool for differential metabolic pathway profiling in functional genomic studies. J Proteome Res (2005) 1.93
Steroidogenic factor 1: an essential mediator of endocrine development. Recent Prog Horm Res (2002) 1.93
Metabonomics in pharmaceutical R&D. FEBS J (2007) 1.93
An opportunistic pathogen isolated from the gut of an obese human causes obesity in germfree mice. ISME J (2012) 1.88
The human gut microbiome: implications for future health care. Curr Gastroenterol Rep (2008) 1.84
Metabonomics in ulcerative colitis: diagnostics, biomarker identification, and insight into the pathophysiology. J Proteome Res (2010) 1.84
A genome-wide metabolic QTL analysis in Europeans implicates two loci shaped by recent positive selection. PLoS Genet (2011) 1.83
Scaling and normalization effects in NMR spectroscopic metabonomic data sets. Anal Chem (2006) 1.81
Metabonomics technologies and their applications in physiological monitoring, drug safety assessment and disease diagnosis. Biomarkers (2004) 1.79
Cell-specific knockout of steroidogenic factor 1 reveals its essential roles in gonadal function. Mol Endocrinol (2004) 1.79
Global metabolic responses of NMRI mice to an experimental Plasmodium berghei infection. J Proteome Res (2008) 1.78
NMR-based metabolic profiling and metabonomic approaches to problems in molecular toxicology. Chem Res Toxicol (2008) 1.77
Assessment of analytical reproducibility of 1H NMR spectroscopy based metabonomics for large-scale epidemiological research: the INTERMAP Study. Anal Chem (2006) 1.76
High-resolution magic-angle-spinning NMR spectroscopy for metabolic profiling of intact tissues. Nat Protoc (2010) 1.76
Melamine-induced renal toxicity is mediated by the gut microbiota. Sci Transl Med (2013) 1.75
Understanding the role of gut microbiome-host metabolic signal disruption in health and disease. Trends Microbiol (2011) 1.72
Metabonomic and microbiological analysis of the dynamic effect of vancomycin-induced gut microbiota modification in the mouse. J Proteome Res (2008) 1.67
Direct quantitative trait locus mapping of mammalian metabolic phenotypes in diabetic and normoglycemic rat models. Nat Genet (2007) 1.66
Application of chemometrics to 1H NMR spectroscopic data to investigate a relationship between human serum metabolic profiles and hypertension. Analyst (2003) 1.65
The gut microbiota, obesity and insulin resistance. Mol Aspects Med (2012) 1.64
Spectroscopic and statistical techniques for information recovery in metabonomics and metabolomics. Annu Rev Anal Chem (Palo Alto Calif) (2008) 1.63
Statistical heterospectroscopy, an approach to the integrated analysis of NMR and UPLC-MS data sets: application in metabonomic toxicology studies. Anal Chem (2006) 1.61
Human metabolic profiles are stably controlled by genetic and environmental variation. Mol Syst Biol (2011) 1.60
Recursive segment-wise peak alignment of biological (1)h NMR spectra for improved metabolic biomarker recovery. Anal Chem (2009) 1.59
Budget impact and sustainability of medical care management for persons with serious mental illnesses. Am J Psychiatry (2011) 1.59
Rapid diagnosis and staging of colorectal cancer via high-resolution magic angle spinning nuclear magnetic resonance (HR-MAS NMR) spectroscopy of intact tissue biopsies. Ann Surg (2014) 1.58
Top-down systems biology modeling of host metabotype-microbiome associations in obese rodents. J Proteome Res (2009) 1.57
IL-22 deficiency alters colonic microbiota to be transmissible and colitogenic. J Immunol (2013) 1.57
The Health and Recovery Peer (HARP) Program: a peer-led intervention to improve medical self-management for persons with serious mental illness. Schizophr Res (2010) 1.56
Gut microbiota composition and activity in relation to host metabolic phenotype and disease risk. Cell Metab (2012) 1.55
Leucine deprivation increases hepatic insulin sensitivity via GCN2/mTOR/S6K1 and AMPK pathways. Diabetes (2011) 1.55
Metabonomics techniques and applications to pharmaceutical research & development. Pharm Res (2006) 1.55
Mistargeting of peroxisomal EHHADH and inherited renal Fanconi's syndrome. N Engl J Med (2014) 1.53
Inter-species transplantation of gut microbiota from human to pigs. ISME J (2007) 1.52
Use of relaxation-edited one-dimensional and two dimensional nuclear magnetic resonance spectroscopy to improve detection of small metabolites in blood plasma. Anal Biochem (2004) 1.51
Urinary metabolic phenotyping differentiates children with autism from their unaffected siblings and age-matched controls. J Proteome Res (2010) 1.50
Determining the in-hospital cost of bleeding in patients undergoing percutaneous coronary intervention. J Interv Cardiol (2009) 1.47
Coordinated multitissue transcriptional and plasma metabonomic profiles following acute caloric restriction in mice. Physiol Genomics (2006) 1.47
Structural changes of gut microbiota during berberine-mediated prevention of obesity and insulin resistance in high-fat diet-fed rats. PLoS One (2012) 1.46
Seipin ablation in mice results in severe generalized lipodystrophy. Hum Mol Genet (2011) 1.46
Structural resilience of the gut microbiota in adult mice under high-fat dietary perturbations. ISME J (2012) 1.46
Therapeutic modulation of microbiota-host metabolic interactions. Sci Transl Med (2012) 1.45
So what's the deal with metabonomics? Anal Chem (2003) 1.43
A metabonomic strategy for the detection of the metabolic effects of chamomile (Matricaria recutita L.) ingestion. J Agric Food Chem (2005) 1.42
NMR spectroscopic-based metabonomic studies of urinary metabolite variation in acclimatizing germ-free rats. Chem Res Toxicol (2003) 1.42
Metabolome, transcriptome, and bioinformatic cis-element analyses point to HNF-4 as a central regulator of gene expression during enterocyte differentiation. Physiol Genomics (2006) 1.42
The Consortium for Metabonomic Toxicology (COMET): aims, activities and achievements. Pharmacogenomics (2005) 1.41
High-throughput 1H NMR-based metabolic analysis of human serum and urine for large-scale epidemiological studies: validation study. Int J Epidemiol (2008) 1.39
The comparison of plasma deproteinization methods for the detection of low-molecular-weight metabolites by (1)H nuclear magnetic resonance spectroscopy. Anal Biochem (2002) 1.38
Assignment of 1H nuclear magnetic resonance visible polyunsaturated fatty acids in BT4C gliomas undergoing ganciclovir-thymidine kinase gene therapy-induced programmed cell death. Cancer Res (2003) 1.38
Structural modulation of gut microbiota in life-long calorie-restricted mice. Nat Commun (2013) 1.36
Nephrocalcinosis (enamel renal syndrome) caused by autosomal recessive FAM20A mutations. Nephron Physiol (2013) 1.31
Opening up the "Black Box": metabolic phenotyping and metabolome-wide association studies in epidemiology. J Clin Epidemiol (2010) 1.31
National survey of the medical treatment status for non-small cell lung cancer (NSCLC) in China. Lung Cancer (2012) 1.30
An integrated metabonomic investigation of acetaminophen toxicity in the mouse using NMR spectroscopy. Chem Res Toxicol (2003) 1.30
Optimization and evaluation of metabolite extraction protocols for untargeted metabolic profiling of liver samples by UPLC-MS. Anal Chem (2010) 1.30
Species variation in the fecal metabolome gives insight into differential gastrointestinal function. J Proteome Res (2007) 1.30
Impact of analytical bias in metabonomic studies of human blood serum and plasma. Anal Chem (2006) 1.29